AI-generated summary
The authors systematically reviewed 22 clinical trials of high-powered 1064 nm photobiomodulation across knee, spine, shoulder, wound, gynecological and osteoporosis conditions. They report statistically significant pain reduction in 90% of pain assessments and improvements in functional measures in all 18 studies assessing them, with the largest effect size for knee arthritis pain. The authors note that more studies are needed to validate these single-trial findings.
- Studies included
- 22
- Who or what was studied
- Patients with a medical diagnosis in clinical trials of high-powered 1064 nm photobiomodulation, including knee arthropathies, spine, shoulder/elbow, wound, gynecological and osteoporosis conditions
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The authors state that the conclusions are limited and that more studies are needed for clinical validation of single-trial data on musculoskeletal conditions, cartilage thickness and bone density.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm, 635-650 nm, 810-850 nm, 915-980 nm
- Power
- 0.5 W
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Wavelength, Photobiomodulation therapy, Systematic review, Meta-analysis, Low-level laser therapy, Effect size, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.